Pages that link to "Q30573765"

The following pages link to Active safety monitoring of newly marketed medications in a distributed data network: application of a semi-automated monitoring system (Q30573765):

Displaying 19 items.

• Pharmacovigilance Using Clinical Notes (Q30058397) (← links)
• A modular, prospective, semi-automated drug safety monitoring system for use in a distributed data environment. (Q30812957) (← links)
• A Method to Combine Signals from Spontaneous Reporting Systems and Observational Healthcare Data to Detect Adverse Drug Reactions (Q30979182) (← links)
• "First-wave" bias when conducting active safety monitoring of newly marketed medications with outcome-indexed self-controlled designs (Q34430193) (← links)
• Near-real-time monitoring of new drugs: an application comparing prasugrel versus clopidogrel. (Q35089550) (← links)
• Developing alerting thresholds for prospective drug safety monitoring. (Q35848816) (← links)
• Calendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy (Q36859634) (← links)
• Development of a detection algorithm for statin-induced myopathy using electronic medical records (Q38093266) (← links)
• Sequential value-of-information assessment for prospective drug safety monitoring using claims databases: the comparative safety of prasugrel v. clopidogrel. (Q38127002) (← links)
• Strength of evidence for labeled dosing recommendations in renal impairment (Q39250007) (← links)
• Transparency and Reproducibility of Observational Cohort Studies Using Large Healthcare Databases. (Q40185232) (← links)
• Propensity Score Weighting Compared to Matching in a Study of Dabigatran and Warfarin. (Q40449888) (← links)
• Pharmacovigilance using Clinical Text (Q42925545) (← links)
• Changing patterns of use of osteoporosis medications in the years after launch: implications for comparative effectiveness research. (Q46262689) (← links)
• Development and application of two semi-automated tools for targeted medical product surveillance in a distributed data network (Q47369849) (← links)
• Advancing the science of pharmacovigilance (Q51214332) (← links)
• Comparison group selection in the presence of rolling entry for health services research: Rolling entry matching (Q58564670) (← links)
• Using Real-World Data to Extrapolate Evidence From Randomized Controlled Trials (Q64122862) (← links)
• The EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study programme: Design and exposure accrual for an evaluation of empagliflozin in routine clinical care (Q92544146) (← links)